A novel immunofluorescent assay to investigate oxidative phosphorylation deficiency in mitochondrial myopathy: Understanding mechanisms and improving diagnosis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Rocha, Mariana C ^a,b   Grady, John P ^b   Grünewald, Anne ^b   Vincent, Amy ^b   Dobson, Philip F ^a   Taylor, Robert W ^b   Turnbull, Doug M ^a,b   Rygiel, Karolina A ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; MULTIENZYME COMPLEX; SUCCINATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; CELL RESPIRATION; CHILD; ELECTRON TRANSPORT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; METABOLISM; MIDDLE AGED; MITOCHONDRIAL MYOPATHIES; MITOCHONDRION; MUTATION; OBSERVER VARIATION; OXIDATIVE PHOSPHORYLATION; PATHOLOGY; PHENOTYPE; PRESCHOOL CHILD; REPRODUCIBILITY; SKELETAL MUSCLE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CELL RESPIRATION; CHILD; CHILD, PRESCHOOL; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL MYOPATHIES; MUSCLE, SKELETAL; MUTATION; OBSERVER VARIATION; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; REPRODUCIBILITY OF RESULTS; SUCCINATE DEHYDROGENASE; YOUNG ADULT;

EID: 84944338845     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15037     Document Type: Article

References (61)

1. Gorman, G. S. et al. Prevalence of nuclear and mtDNA mutations related to adult mitochondrial disease. Ann Neurol 77, 753-759 (2015).
2. Greaves, L. C., Reeve, A. K., Taylor, R. W. & Turnbull, D. M. Mitochondrial DNA and disease. J Pathol 226, 274-286 (2012).
3. Campbell, G. R. et al. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69, 481-492 (2011).
4. Oldfors, A., Larsson, N.-G., Lindberg, C. & Holme, E. Mitochondrial DNA deletions in inclusion body myositis. Brain 116, 325-336 (1993).
5. Reeve, A. K. et al. Nature of mitochondrial DNA deletions in substantia nigra neurons. Am J Hum Genet 82, 228-235 (2008).
6. Pitceathly, R. D. & McFarland, R. Mitochondrial myopathies in adults and children: management and therapy development. Curr Opin Neurol 27, 576-582 (2014).
7. Taylor, R. W., Schaefer, A. M., Barron, M. J., McFarland, R. & Turnbull, D. M. The diagnosis of mitochondrial muscle disease. Neuromuscul Disord 14, 237-245 (2004).
8. McFarland, R., Taylor, R. W. & Turnbull, D. M. A neurological perspective on mitochondrial disease. The Lancet Neurology 9, 829-840 (2010).
9. Johnson, M. A., Turnbull, D. M., Dick, D. J. & Sherratt, H. S. A partial deficiency of cytochrome c oxidase in chronic progressive external ophthalmoplegia. J Neurol Sci 60, 31-53 (1983).
10. Sciacco, M., Bonilla, E., Schon, E. A., DiMauro, S. & Moraes, C. T. Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum Mol Genet 3, 13-19 (1994).
11. Kirby, D. M., Thorburn, D. R., Turnbull, D. M. & Taylor, R. W. Biochemical assays of respiratory chain complex activity. Methods Cell Biol 80, 93-119 (2007).
12. Old, S. L. & Johnson, M. A. Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem J 21, 545-555 (1989).
13. Sciacco, M. & Bonilla, E. Cytochemistry and immunocytochemistry of mitochondria in tissue sections. Methods Enzymol 264, 509-521 (1996).
14. Choudhury, K. R., Yagle, K. J., Swanson, P. E., Krohn, K. A. & Rajendran, J. G. A robust automated measure of average antibody staining in immunohistochemistry images. J Histochem Cytochem 58, 95-107 (2010).
15. Rizzardi, A. E. et al. Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagn Pathol 7, 42 (2012).
16. Janssen, R. J., Nijtmans, L. G., van den Heuvel, L. P. & Smeitink, J. A. Mitochondrial complex I: structure, function and pathology. J Inherit Metab Dis 29, 499-515 (2006).
17. Loeffen, J. L. et al. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 15, 123-134 (2000).
18. Rygiel, K. A. et al. Mitochondrial and inflammatory changes in sporadic Inclusion Body Myositis. Neuropathol Appl Neurobiol 41, 288-303 (2015).
19. Chinnery, P. F., Howel, D., Turnbull, D. M. & Johnson, M. A. Clinical progression of mitochondrial myopathy is associated with the random accumulation of cytochrome c oxidase negative skeletal muscle fibres. J Neurol Sci 211, 63-66 (2003).
20. Horvath, R. et al. Spontaneous recovery of a childhood onset mitochondrial myopathy caused by a stop mutation in the mitochondrial cytochrome c oxidase III gene. Lancet Neurol 41, e75 (2004).
21. Taivassalo, T. et al. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain 129, 3391-3401 (2006).
22. Murphy, J. L. et al. Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 131, 2832-2840 (2008).
23. Perales-Clemente, E. et al. Five entry points of the mitochondrially encoded subunits in mammalian complex I assembly. Mol Cell Biol 30, 3038-3047 (2010).
24. R: A language and environment for statistical computing (R Foundation for Statistical Computing, Vienna, Austria, 2014).
25. Box, G. E. P. & Cox, D. R. An Analysis of Transformations. J R Stat Soc Series B Stat Methodol 26, 211-252 (1964).
26. Shapiro, S. S. & Wilk, M. B. An Analysis of Variance Test for Normality (Complete Samples). Biometrika 52, 591-611 (1965).
27. Goodness-of-fit techniques. (Marcel Dekker, Inc., 1986).
28. Murphy, J. L. et al. Cytochrome c oxidase-intermediate fibres: importance in understanding the pathogenesis and treatment of mitochondrial myopathy. Neuromuscul Disord 22, 690-698 (2012).
29. Mula, J., Lee, J. D., Liu, F., Yang, L. & Peterson, C. A. Automated image analysis of skeletal muscle fiber cross-sectional area. J Appl Physiol (1985) 114, 148-155 (2013).
30. Thomson, T. A. et al. HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization. Mod Pathol 14, 1079-1086 (2001).
31. Alvarenga, A. W. et al. A comparison between manual and automated evaluations of tissue microarray patterns of protein expression. J Histochem Cytochem 61, 272-282 (2013).
32. Kloppel, S. et al. Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain 131, 2969-2974 (2008).
33. De Paepe, B. et al. Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects. J Clin Pathol 62, 172-176 (2009).
34. Hanson, B. J., Capaldi, R. A., Marusich, M. F. & Sherwood, S. W. An immunocytochemical approach to detection of mitochondrial disorders. J Histochem Cytochem 50, 1281-1288 (2002).
35. Mahad, D. J. et al. Detection of cytochrome c oxidase activity and mitochondrial proteins in single cells. J Neurosci Methods 184, 310-319 (2009).
36. Rahman, S. et al. Cytochrome oxidase immunohistochemistry: clues for genetic mechanisms. Brain 123 Pt 3, 591-600 (2000).
37. Tritschler, H. J. et al. Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: an immunohistochemical approach. Neurology 41, 300-305 (1991).
38. Grunewald, A. et al. Quantitative quadruple-label immunofluorescence of mitochondrial and cytoplasmic proteins in single neurons from human midbrain tissue. J Neurosci Methods 232, 143-149 (2014).
39. Elson, J. L., Samuels, D. C., Johnson, M. A., Turnbull, D. M. & Chinnery, P. F. The length of cytochrome c oxidase-negative segments in muscle fibres in patients with mtDNA myopathy. Neuromuscul Disord 12, 858-864 (2002).
40. Matsuoka, T., Goto, Y., Hasegawa, H. & Nonaka, I. Segmental cytochrome c-oxidase deficiency in CPEO: teased muscle fiber analysis. Muscle Nerve 15, 209-213 (1992).
41. Campbell, G., Krishnan, K. J., Deschauer, M., Taylor, R. W. & Turnbull, D. M. Dissecting the mechanisms underlying the accumulation of mitochondrial DNA deletions in human skeletal muscle. Hum Mol Genet 23, 4612-4620 (2014).
42. Lazarou, M., Thorburn, D. R., Ryan, M. T. & McKenzie, M. Assembly of mitochondrial complex I and defects in disease. Biochim Biophys Acta 1793, 78-88 (2009).
43. Fernández-Vizarra, E., Tiranti, V. & Zeviani, M. Assembly of the oxidative phosphorylation system in humans: What we have learned by studying its defects. Biochim Biophys Acta 1793, 200-211 (2009).
44. Xu, F., Morin, C., Mitchell, G., Ackerley, C. & Robinson, B. H. The role of the LRPPRC (leucine-rich pentatricopeptide repeat cassette) gene in cytochrome oxidase assembly: mutation causes lowered levels of COX (cytochrome c oxidase) I and COX III mRNA. Biochem J 382, 331-336 (2004).
45. Merante, F. et al. A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec. Am J Hum Genet 53, 481-487 (1993).
46. Mootha, V. K. et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci USA 100, 605-610 (2003).
47. Swalwell, H. et al. Respiratory chain complex I deficiency caused by mitochondrial DNA mutations. Eur J Hum Genet 19, 769-775 (2011).
48. Kirby, D. M. et al. Mutations of the mitochondrial ND1 gene as a cause of MELAS. J Med Genet 41, 784-789 (2004).
49. Huoponen, K., Vilkki, J., Aula, P., Nikoskelainen, E. K. & Savontaus, M. L. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet 48, 1147-1153 (1991).
50. Gorman, G. S. et al. Novel MTND1 mutations cause isolated exercise intolerance, complex I deficiency and increased assembly factor expression. Clin Sci (Lond) 128, 895-904 (2015).
51. Grady, J. P. et al. Disease progression in patients with single, large-scale mitochondrial DNA deletions. Brain 137, 323-334 (2014).
52. He, L. et al. Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucleic Acids Res 30, e68 (2002).
53. Oldfors, A. et al. Mitochondrial DNA deletions and cytochrome c oxidase deficiency in muscle fibres. J Neurol Sci 110, 169-177 (1992).
54. Pitceathly, R. D. et al. Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics. Brain 135, 3392-3403 (2012).
55. Rygiel, K. A., Grady, J. P., Taylor, R. W., Tuppen, H. A. L. & Turnbull, D. M. Triplex real-time PCR-an improved method to detect a wide spectrum of mitochondrial DNA deletions in single cells. Sci Rep 5, 9906, doi: 9910.1038/srep09906 (2015).
56. James, A. M., Wei, Y. H., Pang, C. Y. & Murphy, M. P. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. Biochem J 318 (Pt 2), 401-407 (1996).
57. Nesbitt, V. et al. The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A > G mutation-implications for diagnosis and management. J Neurol Neurosurg Psychiatry 84, 936-938 (2013).
58. Shaag, A., Saada, A., Steinberg, A., Navon, P. & Elpeleg, O. N. Mitochondrial encephalomyopathy associated with a novel mutation in the mitochondrial tRNA(leu)(UUR) gene (A3243T). Biochem Biophys Res Commun 233, 637-639 (1997).
59. Goedkoop, A. Y. et al. Digital image analysis for the evaluation of the inflammatory infiltrate in psoriasis. Arch Dermatol Res 297, 51-59 (2005).
60. Brey, E. M. et al. Automated selection of DAB-labeled tissue for immunohistochemical quantification. J Histochem Cytochem 51, 575-584 (2003).
61. Egger, J., Lake, B. D. & Wilson, J. Mitochondrial cytopathy. A multisystem disorder with ragged red fibres on muscle biopsy. Arch Dis Child 56, 741-752 (1981).